Regorafenib post-marketing surveillance in Japan
The objective of this study is to assess safety and effectiveness of Regorafenib using in real clinical practice
- Patients who are treated with Regorafenib/ STIVARGA and meet the product label.
- Patients who are treated with Regorafenib/ STIVARGA and don’t meet the product label.
Many Locations, Japan
E-mail: clinical-t[email protected]
Phone: (+) 1-888-8422937
Drug Use Investigation of Regorafenib/ STIVARGA for gastrointestinal stromal tumor progressed after cancer chemotherapy